Name: Candel Therapeutics, Inc. (CADL) Balance Sheet
Creator: FinSpry

Candel Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Candel Therapeutics, Inc. (CADL) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	102.65	35.41	70.06	82.64	35.05
Cash & Short-Term Investments	102.65	35.41	70.06	82.64	35.05
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.15	1.38	1.89	2.30	0.09
Total Current Assets	103.80	36.80	71.95	84.95	35.15
Non-Current Assets
Property, Plant & Equipment (Net)	2.73	4.02	5.48	3.84	2.79
Other Non-Current Assets	0.33	0.38	0.27	0.42	0.35
Total Non-Current Assets	3.06	4.40	5.75	4.26	0.00
Total Assets	106.87	41.20	77.69	89.21	38.28
Current Liabilities
Accounts Payable	0.24	0.42	0.38	1.59	0.92
Short-Term Debt	9.90	8.89	0.00	0.00	0.00
Current Portion of Long-Term Debt	9.90	8.89	0.00	0.00	0.00
Accrued Liabilities	4.72	4.36	4.72	3.44	3.14
Other Current Liabilities	22.11	0.40	0.05	0.33	0.19
Total Current Liabilities	37.53	14.18	5.62	5.36	4.71
Non-Current Liabilities
Long-Term Debt	2.60	12.38	20.85	0.56	0.48
Other Non-Current Liabilities	0.00	0.92	1.88	19.15	7.46
Total Non-Current Liabilities	3.01	14.27	24.36	19.71	0.00
Total Liabilities	40.54	28.46	29.98	25.07	12.78
Stockholders' Equity
Common Stock	0.47	0.29	0.29	0.29	0.12
Retained Earnings	-192.21	-137.03	-99.09	-80.30	-44.17
Treasury Stock	0.45	0.45	0.45	0.00	0.00
Additional Paid-in Capital	258.51	149.93	146.96	144.15	0.00
Shares Outstanding	46.81	29.09	28.92	28.69	0.00
Total Stockholders' Equity	66.33	12.75	47.71	64.14	25.50
Total Liabilities & Equity	106.87	41.20	77.69	89.21	0.00